In: PATENT NEWS
The Humira patent estate now comprises secondary patents. While it is hard to comprehend how real estate can grow, the genius of patent law allows the intellectual property estate to expand by filing more secondary patents. Over the years, AbbVie has increased the price of Humira in the U.S. by... Continue reading
In: PATENT NEWS
Marathon Patent Group Announces Rescheduling of Annual Meeting to March 7, 2018 GlobeNewswire (press release) Form DEFA14A Marathon Patent Group, StreetInsider.com Full coverage
In: PATENT NEWS
The PositionTheposition of Associate Director/Director/Senior Director, Patent Law is a seniorlevel attorney position in the patent function of…
In: PATENT NEWS
Big pharma has fought back, of course, by lobbying foreign governments to enforce intellectual property law to protect their monopolies. But the ability of stakeholders in India — an eclectic mix of activists, government officials, generics manufacturers, and very often, doctors like Malhotra — to force down …
In: PATENT NEWS
In its IPR final decision, the PTAB sided with the patentee – holding that Elbit had failed to prove that the challenged claims of Thales patent were obvious. On appeal, the Federal Circuit has affirmed – holding that “substantial evidence” supported the finding. The challenged (U.S. Patent No. 6,474,159) …
In: PATENT NEWS
Position Number: 27710. Position Title: Patent Legal Executive Assistant | 3+ years | Calgary Position Type: Private Position Category: Trademark Agents / Patent Agents Job Description: Our client, a well-known business law firm, is seeking an experienced Patent Legal/Executive Assistant to join their …
In: PATENT NEWS
According to a schedule Administrative Law Judge Mary Joan McNamara released last May, she plans to have a final determination in the case by early July. The ITC case is just one of several lawsuits Hytera and Motorola have filed against each other around the world since last March. Recent... Continue reading
In: PATENT NEWS
Share. The European Commission has failed to make its case for tinkering with patent law; Stockpiling and export waivers, unlike research, undermine the protection of intellectual property rights; Changes cannot logically be confined to pharmaceuticals, and would have significant impacts. One of the …
In: PATENT NEWS
“A trademark combining colour and shape may be refused or declared invalid on the grounds set out under EU trademark law,” the ECJ said in a statement. The opinion is not binding, but the ECJ tends to follow the opinions of its advocates in its rulings. Which means the attempt... Continue reading
In: PATENT NEWS
Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma GlobeNewswire (press release) Full coverage
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION